Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The Croatian government is to pay for early-stage human epidermal growth factor receptor 2-positive breast cancer patients to receive Roche's Herceptin

    • 12 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Croatia to pay for early-stage Herceptin. Scrip: 8, No. 3246, 30 Mar 2007

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    The Croatian government is to pay for early-stage human epidermal growth factor receptor 2-positive breast cancer patients to receive Roche's Herceptin. Pharmacoecon. Outcomes News 526, 11 (2007). https://doi.org/10.2165/00151234-200705260-00025

    Download citation

    Keywords

    • Public Health
    • Breast Cancer
    • Health Outcome
    • Trastuzumab
    • Human Epidermal Growth Factor Receptor